DA
Dina Alnabwani
Physician · Envision
Credentials: · · ·
History
- 2025–Present
- 2003–2007
Doctor of Medicine
Research
Review · Cureus · 2021 · First of 6 authors · Corresponding · 25 citations
Rare Adverse Events Related to Nivolumab, an Immune Checkpoint Inhibitor: A Case Series
Case report · Cureus · 2022 · 9 citations
Necrotizing Fasciitis: A Life-Threatening Infection Due to Clostridium Species
Case report · Cureus · 2022 · 6 citations
- PC
16 papers
11 papers · 11 as a resident
- VB
8 papers · 7 as a resident
- SH
6 papers · 6 as a resident
- AP
5 papers · 1 as a resident
- AM
2 papers · 2 as a resident
- FA
2 papers · 2 as a resident
- GS
2 papers · 2 as a fellow